Older Men Should Pass on Getting Prostate Cancer Treatment

  • Share
  • Read Later
Dana Neely / Getty Images

The advice to detect and treat cancers at the first opportunity may not apply to older men with prostate tumors, according to the latest study.

With a government-backed group advising that most men no longer need regular screening for prostate cancer with the prostate-specific antigen (PSA) blood test, researchers now say that older men who are diagnosed with the disease should not always get surgery or radiation treatment.

That’s because for most men, having a low to moderate risk of prostate cancer is not a major red flag for early death. The cancer is typically so slow-growing, that many of these men will die from other causes, which means the benefits of treatment do not always outweigh the risks. Surgery, radiation and radioactive seed implants can cause disorders such as erectile dysfunction and urinary incontinence. And since it can take many years for the effects of the treatments to emerge, the survival advantage is low in most cases in which the tumors aren’t aggressive.

(MORE: Genetic Test Can Predict the Most Aggressive Cases of Prostate Cancer)

In the new study, published in the journal Annals of Internal Medicine,  led by researchers at the University of California Los Angeles (UCLA) Department of Urology looked at the 14-year survival of 3,000 men diagnosed with prostate cancer between the years 1994 and 1995. Older men with low to intermediate cases of prostate cancer, who also had at least three other health problems like diabetes, hypertension, congestive heart failure and arthritis, were significantly more likely to die from a cause unrelated to their cancer.

(MOREPared Back Prostate Cancer Screening May Save Lives)

The 10-year risk of dying from these other causes among men aged 61 to 74 was 40%, and for men over 75, it climbed to 71%. The 14-year risk of dying from low or intermediate risk prostate cancer was 3% for men between 61 and 74, and 7% among men over 75. For men with high-risk prostate cancer, the risk of death from the cancer was 18% at the 14-year mark.

“The take home point from this study is that older men with multiple underlying health problems should carefully consider whether they should treat these tumors aggressively, because that treatment comes with a price,” said lead study author Dr. Timothy Daskivich, a UCLA Robert Wood Johnson fellow in a statement.
(MOREThe Link Between Early Baldness and Prostate Cancer)
Determining which types of prostate cancer are aggressive and which are of lower risk is also becoming easier. Earlier this month, TIME’s Alice Park covered a new genetic test for identifying the most agressive forms of prostate cancer. She explains:

Watchful waiting is a common strategy for treating prostate cancer, since in about 40% of cases the tumors are so slow-growing that they don’t require additional, invasive biopsies or treatment and men with the cancer are more likely to die of other causes.

But based on analyses of tissue from men whose prostates were surgically removed as a precaution even if they were deemed to be low-risk, anywhere from 15% to 20% of these low-risk cases actually turn out to involve tumors that were more aggressive. As a result, the tumors were mischaracterized by available predictive methods such as the blood-based prostate specific antigen (PSA) test and imaging to search for hidden growths.

As these types of tests become more available, it may be possible to help more men avoid unnecessary surgery, and the complications that could come along with those procedures, say the study authors. The added information should also help patients with peace of mind in knowing that their “watching waiting” strategy is the right one, as contrary as it may seem when it comes to cancer.
, reports that older prostate cancer patients, who have other underlying health conditions, should reconsider undergoing surgical or radiation treatments for prostate cancer.


You have made some good points there. I checked on the web to find out more about the issue and found most individuals will go along with your views on this web site.

Life Insurance Calgary


SEO alternatives Native indian allows in improving the place of client's website, so that maximum possible leads can be generated. The different types of strategies used by these companies help to improve the web traffic. http://placercountyduiattorney.tripod.com/


We took our son to a developmental pediatrician who diagnosed him as having High Functioning Autism.  She gave us a list of places to take him for special education.  We soon learned that their special education was entirely focused on fixing him. http://www.tristatewildlife.com/


I've been researching prostate cancer for awhile now, and this is something I have come across before. Older individuals aren't great candidates for radiation treatment because, as awful as it sounds, it's possible that they will die of natural causes before prostate cancer. If they elect to undergo radiation treatment, it's possible that the last few years of their lives could be uncomfortable when it doesn't have to. Luckily, my doctor is completely honest about my treatment. http://www.comprehensive-urology.com/our-team/kia-michel-md/


I agree that men, like those characterized above, should be wary of treatments that come with a heavy price with respect to quality of life changing side effects and complications like surgery, external beam radiation, and radioactive seed implants. However, there are many older gentleman with medical problems who lead an active life and aren't at risk of dying in the immediate future. These men should consider treatment with CyberKnife SBRT which is not associated with any severe life changing side effects or complications. I have treated several men like this in my group of over 400 patients who I have treated with CyberKnife SBRT and they are extremely pleased with the results and quality of life after treatment.


One might think it prudent to switch to a low iron vegetarian diet.

"Bowel cancers were two to three times more likely to develop in mice with a faulty APC gene that were fed high amounts of iron".
"Planning to develop treatments that reduce the amount of iron in the bowel and so could lower the risk of developing bowel cancer".